Analysis of Chemical and Potential Anti‐Heart Failure Components of Yan‐Shi‐Qiang‐Xin Decoction by UHPLC‐Q‐Orbitrap HRMS Coupled With Molecular Networking
Biomedical Chromatography · 2025
DOI: 10.1002/bmc.70100 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, 2025. Verfasst von Wen-Chao Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Heart Failure. Die Arbeit nennt 32 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Traditional Chinese Medicine Guangdong Provincial Laboratory Scientific Research and Development Incubation Project, Shanghai Sailing Program.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Yan‐Shi‐Qiang‐Xin decoction (YSQXD), a traditional Chinese medicine formula, is clinically effective in treating chronic heart failure, yet its bioactive constituents remain unclear. To address this, a sensitive and reliable UHPLC‐Q‐Exactive Orbitrap HRMS method was established to separate and identify the chemical constituents in YSQXD and its absorbed constituents in rat serum, heart and liver following oral administration of YSQXD. With the optimized conditions, a total of 134 chemical components were tentatively identified, including 41 terpenoids, 34 flavonoids, 19 alkaloids, nine organic acids, eight amino acids, seven coumarins, six nucleotides, two sterols, and eight other compounds, based on retention times, MS/MS spectra, and literature references. Furthermore, 29, 10, 17 constituents were identified in the rat serum, heart and liver, respectively. Finally, the network pharmacology analysis based on absorbable components indicated that polyporenic acid, bavachalcone, albiflorin, biatractylolide, psoralen, angelicin, neobavaisoflavone, dictysine, isotalatizidine, and 26‐hydroxyporicoic acid G exhibited high degree values, suggesting their potential as active ingredients for chronic heart failure treatment. These findings provide a comprehensive chemical profile of YSQXD and its absorbed components, offering valuable insights into its pharmacologically active substances.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
- Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.
- Department of Internal Medicine of TCM, Shanghai Municipal Hospital of Traditional Chinese Medicine Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.
- Institute of Science, Technology and Humanities, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
ORCID-Profile: Ping Wang
Förderung
- National Natural Science Foundation of China
- Traditional Chinese Medicine Guangdong Provincial Laboratory Scientific Research and Development Incubation Project
- Shanghai Sailing Program
Zitieren
APA
Chen, W. C., Fang, Q. Q., Qin, Y., Li, R. S., Zhang, Q. G., Liu, W., Wang, P., & Zhu, S. X. (2025). Analysis of Chemical and Potential Anti‐Heart Failure Components of Yan‐Shi‐Qiang‐Xin Decoction by UHPLC‐Q‐Orbitrap HRMS Coupled With Molecular Networking. Biomedical Chromatography. https://doi.org/10.1002/bmc.70100
Vancouver
Chen WC, Fang QQ, Qin Y, Li RS, Zhang QG, Liu W, et al. Analysis of Chemical and Potential Anti‐Heart Failure Components of Yan‐Shi‐Qiang‐Xin Decoction by UHPLC‐Q‐Orbitrap HRMS Coupled With Molecular Networking. Biomedical Chromatography. 2025. doi:10.1002/bmc.70100
BibTeX
@article{Chen2025,
author = {Chen, Wen-Chao and Fang, Qin-Qin and Qin, Yan and Li, Rong-Sheng and Zhang, Qing-Guang and Liu, Wei and Wang, Ping and Zhu, Si-Xing},
title = {Analysis of Chemical and Potential Anti‐Heart Failure Components of Yan‐Shi‐Qiang‐Xin Decoction by UHPLC‐Q‐Orbitrap HRMS Coupled With Molecular Networking},
journal = {Biomedical Chromatography},
year = {2025},
doi = {10.1002/bmc.70100}
}
EUVIMED